Merck's Prometheus Acquisition Is A Step In The Right Direction

Apr. 17, 2023 12:09 PM ETMerck & Co., Inc. (MRK) StockMRK6 Comments
The Value Portfolio
Investing Group Leader

Summary

  • Merck is facing the LOE on Keytruda before the end of the decade, which makes up more than 35% of the company's revenue.
  • The company has an impressive portfolio of assets, but its pipeline is sparse and its valuation is higher.
  • The company's Prometheus acquisition is incredibly promising and the premium the company is willing to pay highlights the strength of the asset.
  • We expect the company to continue its growth and future shareholder returns.
  • We're currently running a sale for our private investing group, The Retirement Forum, where members get access to portfolios, market alerts, real-time chat, and more. Learn More »

Merck Research Facility South San Francisco

JasonDoiy

Merck (NYSE:MRK) is an American multinational pharmaceutical company worth just a hair under $300 billion. The company has a dividend yield of just over 2.5% and a higher valuation with an incredibly well distributed portfolio of assets. As we'll see throughout this

You Only Get 1 Chance To Retire, Join The #1 Retirement Service

The Retirement Forum provides actionable ideals, a high-yield safe retirement portfolio, and macroeconomic outlooks, all to help you maximize your capital and your income. We search the entire market to help you maximize returns.

Recommendations from a top 0.2% TipRanks author!

Retirement is complicated and you only get one chance to do it right. Don't miss out because you didn't know what was out there.

Only 4% of Americans Are Taking Advantage of This Smart Retirement Move | The Motley Fool

We provide:

  • Model portfolios to generate high retirement cash flow.
  • Deep-dive actionable research.
  • Recommendation spreadsheets and option strategies.

Click for our discounted 2-week free trial!

This article was written by

The Value Portfolio
36.18K Followers

The Value Portfolio specializes in building retirement portfolios and utilizes a fact-based research strategy to identify investments. This includes extensive readings of 10Ks, analyst commentary, market reports, and investor presentations. He invests real money in the stocks he recommends.

He is the leader of the investing group The Retirement Forum with features including: model portfolios, macro overviews, in-depth company analysis and retirement planning information. Learn more.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of MRK either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About MRK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on MRK

Related Stocks

SymbolLast Price% Chg
MRK
--
Compare

Trending Analysis

Trending News